Law Firm Files Class Action Against Hims & Hers Over Data Privacy Claims
Pomerantz LLP has filed a class action lawsuit against Hims & Hers Health, Inc. The suit alleges securities fraud and unlawful business practices related to data sharing and billing.
Law firm Pomerantz LLP announced on September 24, 2026, that it has filed a class action lawsuit against Hims & Hers Health, Inc. The suit accuses the company and certain of its officers and directors of engaging in securities fraud and other unlawful business practices.
Investors who purchased Hims & Hers securities during the specified class period and suffered losses have until November 2, 2026, to petition the court to be appointed Lead Plaintiff. The lawsuit stems from allegations made in a Federal Trade Commission (FTC) complaint filed on July 29, 2026. The FTC alleged that Hims & Hers shared sensitive consumer health information with third-party advertising platforms like Meta and Snap, despite privacy assurances.
The FTC complaint also detailed accusations of deceptive billing and cancellation practices. Hims & Hers allegedly charges consumers for prescriptions almost immediately after they submit an intake form, contrary to promises of consulting with a medical provider to find the right treatment. This news resulted in a significant drop in Hims & Hers' stock price, falling 14.73% on July 29, 2026.
Pomerantz LLP, with offices in multiple international locations, specializes in corporate and securities litigation. The firm has a history of recovering substantial damages for class members in securities fraud and misconduct cases.